Bonus BioGroup Ltd. (TLV:BONS)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
19.40
-0.90 (-4.43%)
Jul 1, 2025, 4:21 PM IDT
24.36%
Market Cap 237.09M
Revenue (ttm) n/a
Net Income (ttm) -27.83M
Shares Out 1.17B
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,803,028
Average Volume 1,492,030
Open 20.30
Previous Close 20.30
Day's Range 19.30 - 20.30
52-Week Range 9.00 - 26.70
Beta 0.89
RSI 45.24
Earnings Date May 29, 2025

About Bonus BioGroup

Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company’s products under development include BonoFill for the treatment of bone tissue regeneration in maxillofacial and orthopedic indications, and defects in limb and jaw bones which is in Phase II clinical trial, as well as in a preclinical stage for the treatment of bone augmentation in osteoporosis patients. It also develops MesenCure for the treatment of COVID patients suffering from pneumonia and ARDS which is ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1981
Employees 49
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol BONS
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.